“…That is, both murine and human primed ESCs (most hESC lines), relative to naïve cells, exhibit more heterogeneous expression profiles, often have underwent XCI in female lines, have increased de novo methyl transferase expression, increased class II enhancer marks (poised for activation during differentiation), and a non-uniform differentiation propensity Gafni et al, 2013). So although pluripotency is classically tested as the ability of a stem cell to differentiate into all 3 germ layers and more stringently to form a blastocyst chimera, epigenomic differences whether through crude manipulation of the epigenome (Choi et al, 2004;Yoon et al, 2006;Chow et al, 2013b;Horrillo et al, 2013), adjustments to the microenvironment (Horton et al, 2009;Tompkins et al, 2012), or progressive accumulation of epigenetic changes over passaging (Tanasijevic et al, 2009;Tompkins et al, 2012), can all have defining influences on cell fate.…”